Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that the Company will host a conference call and live audio webcast on Tuesday, March 21, 2017, at 8:30 a.m. ET to discuss its year-end 2016 financial results and provide a business update.
To participate in the call, please dial (866) 682-6100 (domestic) or (862) 255-5401 (international). A live webcast of the call can be accessed under “Events and Presentations” in the Investors section of the Company’s website at www.tenaxthera.com. An archived webcast recording will be available on the Tenax Therapeutics website beginning approximately two hours after the call.
About Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company owns the North American rights to develop and commercialize levosimendan, a novel, first in class calcium sensitizer/K-ATP activator. For more information, visit www.tenaxthera.com.
Stern Investor Relations, Inc.
Will O‘Connor, 212-362-1200